Target Groups for a Short Dexamethasone Course among Critically Ill COVID-19 Patients
Introduction. Corticosteroids are one of the most promising therapeutic agents for critically ill patients with coronavirus disease 2019 (COVID-19). Despite emerging data, assessed populations and regimens vary, and there are patient subgroups whose response to steroids remains unclear. We aimed to...
Saved in:
Main Authors: | Armen Oganesyan, Ruslan Menzulin, Yury Surovoy, Andrei Nikiforchin, Kirill Zykov |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Critical Care Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2021/5557302 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Care of the Critically ill /
Published: (1974) -
Correlation between hemoglobin, albumin, lymphocyte, and platelet score and short-term mortality in critically ill patients
by: Chong Zhang, et al.
Published: (2025-02-01) -
Wish-Granting Interventions Promote Positive Emotions in Both the Short and Long Term in Children with Critical Illnesses and Their Families
by: Hannah Roberts, et al.
Published: (2024-12-01) -
Mycobiome analyses of critically ill COVID-19 patients
by: Danielle Weaver, et al.
Published: (2025-02-01) -
Acute kidney injury in critically ill COVID-19 patients in a tertiary hospital: short and long-term kidney and patient outcomes
by: Juliana Alves Manhães de Andrade, et al.
Published: (2025-01-01)